DAIC

MARCH 28, 2024

milla1cf Thu, 03/28/2024 - 07:30 March 28, 2024 — Medtronic plc, a global leader in healthcare technology, announced that the United States Food and Drug Administration ( FDA ) has approved the Evolut FX+ transcatheter aortic valve replacement (TAVR) system for the treatment of symptomatic severe aortic stenosis.

TAVR 111

TAVR Stenosis Aortic Aortic valve 111

DAIC

JUNE 7, 2024

milla1cf Fri, 06/07/2024 - 14:50 June 7, 2024 — Medtronic today announced new data from the CoreValve Evolut Clinical Program , reinforcing the positive performance of the Evolut transcatheter aortic valve replacement (TAVR) System compared to surgical aortic valve replacement (SAVR) and other TAVR valves. Evolut vs. 10.6%

TAVR 111

TAVR Aortic valve Aortic Stenosis 111

DAIC

MARCH 21, 2024

To this end, ASCEND provides the tools that not only address the unique needs of each cardiovascular subspecialty and to care for patients from infancy into their golden years, they also innovates next-generation solutions and services that empower the provider community to truly transform their cardiovascular services.

Pediatrics 86

Pediatrics Outcomes Patient Care TAVR 86

DAIC

MARCH 25, 2024

We hope that the anniversary contributions will help to support the college's mission and mission-focused work that empowers future leaders in the next generation of cardiovascular innovators through scholarship, mentorship and leadership development programs. “We Session 510) To Treat or Not to Treat Anatomy and Ischemia?

Education 59

Education Cardiogenic Shock Heart Failure Plaque 59